MX2017004909A - Tryptamide compositions and methods of use. - Google Patents

Tryptamide compositions and methods of use.

Info

Publication number
MX2017004909A
MX2017004909A MX2017004909A MX2017004909A MX2017004909A MX 2017004909 A MX2017004909 A MX 2017004909A MX 2017004909 A MX2017004909 A MX 2017004909A MX 2017004909 A MX2017004909 A MX 2017004909A MX 2017004909 A MX2017004909 A MX 2017004909A
Authority
MX
Mexico
Prior art keywords
tryptamide
compositions
methods
tryptamides
eht extract
Prior art date
Application number
MX2017004909A
Other languages
Spanish (es)
Inventor
Jose Fernandez
Stock Jeffry
Stock Maxwell
Voronkov Michael
HUBER Kristen
Original Assignee
Signum Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201462063983P priority Critical
Priority to US201562121711P priority
Application filed by Signum Biosciences Inc filed Critical Signum Biosciences Inc
Priority to PCT/US2015/055745 priority patent/WO2016061357A1/en
Publication of MX2017004909A publication Critical patent/MX2017004909A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415Pyridoxine, i.e. Vitamin B6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135Compounds containing heavy metals
    • A61K31/714Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16Tryptamines

Abstract

EHT extract including a mixture of late eluting tryptamides and early eluting tryptamides in a weight ratio of at least about 7: 1 late eluting tryptamides:early eluting tryptamides, wherein the EHT extract includes at least 30% eicosanoyl-5-hydroxytryptamide, based on the total weight of the tryptamides in the EHT extract.
MX2017004909A 2014-10-15 2015-10-15 Tryptamide compositions and methods of use. MX2017004909A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US201462063983P true 2014-10-15 2014-10-15
US201562121711P true 2015-02-27 2015-02-27
PCT/US2015/055745 WO2016061357A1 (en) 2014-10-15 2015-10-15 Tryptamide compositions and methods of use

Publications (1)

Publication Number Publication Date
MX2017004909A true MX2017004909A (en) 2018-02-12

Family

ID=55747349

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017004909A MX2017004909A (en) 2014-10-15 2015-10-15 Tryptamide compositions and methods of use.

Country Status (13)

Country Link
US (1) US10314817B2 (en)
EP (1) EP3207029B1 (en)
JP (2) JP2017531698A (en)
KR (1) KR20170066645A (en)
CN (1) CN107108495B (en)
AU (1) AU2015332434A1 (en)
CA (1) CA2963982A1 (en)
CO (1) CO2017004809A2 (en)
HK (1) HK1243404A1 (en)
MX (1) MX2017004909A (en)
PE (1) PE20171059A1 (en)
TW (1) TW201630882A (en)
WO (1) WO2016061357A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106565588A (en) * 2016-11-10 2017-04-19 徐州工程学院 Method for extracting food source eicosanoic acid-5-hydroxytryptamine from nuts
WO2020092930A1 (en) * 2018-11-02 2020-05-07 Rutgers, The State University Of New Jersey Synergistic composition having neuroprotective properties and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2639066C2 (en) * 1976-08-30 1989-07-13 Hag Ag, 2800 Bremen, De
EP0693547B1 (en) * 1994-07-23 2001-01-24 Societe Des Produits Nestle S.A. Antioxidant composition and process for the preparation thereof
JPH08157816A (en) * 1994-12-02 1996-06-18 Oriza Yuka Kk Natural antioxidant and its production
WO2009132051A1 (en) * 2008-04-21 2009-10-29 Signum Biosciences, Inc. Compounds, compositions and methods for making the same
DE202008005965U1 (en) 2008-04-30 2008-12-11 Metsälä, Pertti food composition
EP2382868A1 (en) 2010-04-30 2011-11-02 Tchibo GmbH Healthy coffee and method of its production
KR101860165B1 (en) * 2010-10-13 2018-05-21 인터컨티넨탈 그레이트 브랜즈 엘엘씨 Coffee extracts as ingredients of foods, drugs, cosmetics, dietary supplements, and biologics
WO2012121381A1 (en) * 2011-03-10 2012-09-13 高砂香料工業株式会社 Taste improvement agent
US8877766B2 (en) * 2013-02-15 2014-11-04 Peter F. Kador Neuroprotective multifunctional antioxidants and their monofunctional analogs

Also Published As

Publication number Publication date
PE20171059A1 (en) 2017-07-21
CO2017004809A2 (en) 2017-11-21
JP2017531698A (en) 2017-10-26
WO2016061357A1 (en) 2016-04-21
HK1243404A1 (en) 2018-07-13
CN107108495A (en) 2017-08-29
KR20170066645A (en) 2017-06-14
EP3207029A4 (en) 2018-05-02
JP2021059543A (en) 2021-04-15
US10314817B2 (en) 2019-06-11
CN107108495B (en) 2021-07-16
CA2963982A1 (en) 2016-04-21
EP3207029B1 (en) 2021-08-04
EP3207029A1 (en) 2017-08-23
AU2015332434A1 (en) 2017-04-20
US20170231955A1 (en) 2017-08-17
TW201630882A (en) 2016-09-01

Similar Documents

Publication Publication Date Title
MY191035A (en) Affinity-oligonucleotide conjugates and uses thereof
SG10201803042PA (en) Anti-tim-3 antibodies
WO2015200902A8 (en) Endophytes, associated compositions, and methods of use thereof
MX2019009842A (en) Solid composition comprising amorphous sofosbuvir.
MY191581A (en) Anti-pd-1 antibodies
TN2017000246A1 (en) Anti-c10orf54 antibodies and uses thereof
MX2019007021A (en) Il-11ra antibodies.
MX2019007020A (en) Il-11 antibodies.
WO2016044189A8 (en) Methods of treating cancer using pd-1 axis binding antagonists and il-17 binding antagonists
IL273300A (en) High dosage valbenazine formulation and compositions, methods, and kits related thereto
SG10201808835QA (en) Anti-siglec-8 antibodies and methods of use thereof
MX2019010594A (en) Beta-casein a2 and prevention of inflammation of the bowel.
MX2017008390A (en) Alkoxysilane-functionalized and allophanate-functionalized urethanes.
TN2017000435A1 (en) [bis(trihydrocarbylsilyl)aminosilyl]-functionalized styrene and a method for its preparation
SG10201808278TA (en) Polishing composition and polishing method
MX2015008952A (en) Method for preparing instant noodle, flour composition for instant noodle and use thereof.
UA123989C2 (en) Nitrification inhibitor compositions and methods for preparing the same
SG10201900598TA (en) Factor viii formulation
GB201804163D0 (en) Uses, compositions and methods
MX2016017142A (en) Allisartan isoproxil solid dispersion and pharmaceutical composition comprising same.
IL280809B (en) Novel compositions, their use, and methods for their formation
MX2017004909A (en) Tryptamide compositions and methods of use.
EP3140429A4 (en) Methods and compositions for scd, crt, crt-d, or sca therapy identification and/or selection
MX2018004924A (en) Dry, flowable sabadilla extract.
WO2015108945A3 (en) Compositions and methods for the delivery of therapeutics